These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 21778707

  • 1. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Amemiya N, Ochi A, Tsuruta Y, Shimizu A, Itabashi M, Takei T, Uchida K, Nitta K.
    Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 3. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 4. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 5. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [Abstract] [Full Text] [Related]

  • 6. Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T, Amamiya N, Ochi A, Tsuruta Y, Shimizu A, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.
    Clin Exp Nephrol; 2011 Oct; 15(5):700-707. PubMed ID: 21625892
    [Abstract] [Full Text] [Related]

  • 7. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 8. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 9. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T, Nakayama K, Ochi A, Amemiya N, Tsuruta Y, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.
    Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
    [Abstract] [Full Text] [Related]

  • 13. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C, Ravani P, Torres D, Prati E, Viola BF, Guerini S, Foramitti M, Frascà G, Amoroso A, Ghiggeri GM, Schena FP, Scolari F.
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [Abstract] [Full Text] [Related]

  • 14. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group.
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate.
    Okonogi H, Utsunomiya Y, Miyazaki Y, Koike K, Hirano K, Tsuboi N, Suzuki T, Hara Y, Ogura M, Hosoya T, Kawamura T.
    Nephron Clin Pract; 2011 Mar; 118(3):c292-300. PubMed ID: 21212693
    [Abstract] [Full Text] [Related]

  • 18. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
    Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.
    Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
    [Abstract] [Full Text] [Related]

  • 19. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D, Bauerova L, Skibova J, Rysava R, Reiterova J, Merta M, Honsova E, Tesar V.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [Abstract] [Full Text] [Related]

  • 20. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C, Del Vecchio L, Locatelli F.
    G Ital Nefrol; 2002 Apr; 19(5):523-8. PubMed ID: 12439840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.